Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > If imnp sells ico008

<< Previous

Bullboard Posts

Next >>

Post by juansitoon Jan 04, 2019 7:58am

85 Views

Post# 29185182

If imnp sells ico008

And Ico get some cash for that and apply on Phase 2 ico19 no need of pp. That can send us back to 20s in no time. GLTA!!! PS I need to said something negative in order to promote the rally... Lol So Ico will go back to 5 cent!!! Miga!

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments